Zhejiang Orient Gene Biotech Competitors and Similar CompaniesClear all

Zhejiang Orient Gene Biotech's competitors and similar companies include Transasia Bio-Medicals, Allengers Medical Systems, Autobio Diagnostics and Ortho Clinical Diagnostics US.

	Zhejiang Orient Gene Biotech Zhejiang Orient Gene Biotech (浙江东方基因生物制品股份有限公司) is a company that manufactures and sells vitro diagnostic products,	Transasia Bio-Medicals Transasia Bio-Medicals is a developer and manufacturer of healthcare products.	Allengers Medical Systems Allengers Medical Systems is a manufacturer and supplier of medical diagnostic equipment.	Autobio Diagnostics Autobio Diagnostics (奧託生物診斷有限公司) is a manufacturer and supplier of medical diagnostics products.	Ortho Clinical Diagnostics US Ortho Clinical Diagnostics US is a company specializing in in vitro diagnostics.
Founding Date	Founding Date 2005	Founding Date 1979	Founding Date 1987	Founding Date 1998	Founding Date 1994
Type	Type Public	Type Subsidiary	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics
Locations	Locations Huzhou, CN HQ	Locations HQ	Locations HQ	Locations Zheng Zhou Shi, CN HQ	Locations Raritan, US HQ Rochester, US
Employees	Employees 2,231	Employees 2,0351% increase	Employees 961	Employees 5,773	Employees 1,650
Valuation ($)	Valuation ($) 945.9 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 3.6 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) ¥910.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥4.1b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods ¥560.9m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥1.5b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit ¥366.6m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit ¥2.7b (FY, 2025)	Gross profit N/A
Net income	Net income (¥597.4m) (FY, 2025)	Net income N/A	Net income N/A	Net income ¥1.1b (FY, 2025)	Net income N/A